HER2-positive Carcinoma of Breast
1 competing product in clinical development for HER2-positive Carcinoma of Breast.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab | Celltrion | Phase 3 | Completed | 77 |
1 competing product in clinical development for HER2-positive Carcinoma of Breast.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab | Celltrion | Phase 3 | Completed | 77 |